Related by context. Frequent words. (Click for all words.) 62 heavily pretreated 62 refractory chronic lymphocytic 60 neoadjuvant 60 metastatic hormone refractory 59 decitabine 59 neoadjuvant chemotherapy 58 mRCC 58 daunorubicin 58 refractory multiple myeloma 58 plus prednisone 58 advanced carcinoid 58 CD# + [001] 58 metastatic lung cancer 57 HER2 positive metastatic breast 57 neoadjuvant therapy 57 interferon alfa 57 metastatic renal cell carcinoma 57 bleomycin 57 androgen deprivation 57 cell acute lymphoblastic 57 acute myelogenous leukemia AML 57 R sorafenib tablets 57 androgen independent 57 radical nephrectomy 57 Natalizumab 57 KRAS mutations 56 FOLFOX4 56 Laquinimod 56 epirubicin 56 KRAS wild 56 adjuvant radiation 56 bendamustine 56 biochemical recurrence 56 N Engl J 56 poorer prognosis 56 sulfasalazine 56 virologic failure 56 DOXIL 56 colorectal carcinoma 56 chemoradiotherapy 56 distant metastasis 56 mycophenolate mofetil 55 T2DM 55 annualized relapse 55 leukemia CLL 55 noncarriers 55 Capecitabine 55 Paraplatin 55 Torisel 55 μmol L 55 relapsing multiple sclerosis 55 sustained virologic response 55 Arch Intern Med 55 heavily pretreated patients 55 Combination therapy 55 cabazitaxel 55 advanced adenomas 55 malignant pleural mesothelioma 55 relapsing remitting 55 forodesine 55 HER2 negative 55 RRMS patients 54 carboplatin paclitaxel 54 pg ml 54 Taxotere ® 54 mg QD 54 grade gliomas 54 Etanercept 54 coinfected 54 tamoxifen therapy 54 chlorambucil 54 acute promyelocytic leukemia APL 54 superficial bladder cancer 54 univariate 54 Cancer Res 54 interferon therapy 54 unresectable 54 vinorelbine 54 peginterferon alfa 54 breast carcinoma 54 fluorouracil 54 non squamous NSCLC 54 confidence interval #.#-#.# 54 recurrent glioblastoma 54 virological failure 53 FOLFIRI 53 mitoxantrone 53 gastrointestinal stromal tumors 53 severe renal impairment 53 beta blocker therapy 53 IV melanoma 53 relapsed refractory multiple myeloma 53 MGUS 53 epithelial ovarian cancer 53 leukemia ALL 53 resectable 53 serum PSA 53 follicular non 53 Median progression 53 Metastatic Melanoma 53 Fludara